GPT and metabolic dysfunction-associated steatotic liver disease: The results of these studies showed improvements in the progression of hepatosteatosis and decrease in serum liver biological markers (AST and ALT), however there was still no evidence of improvements in echoic NAFLD image findings [40,41].